authorization

(redirected from authorisations)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

Authorization

The granting of access to a document or the ability to conduct an activity. Authorization may be limited to a certain transaction or time period, or it may be unlimited. For example, a potential home buyer may grant a lender authorization to view his/her credit reports.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved

authorization

the granting of permission by a senior manager to a subordinate to undertake a particular task. For example, the chief executive could empower his purchasing officer to buy raw materials and authorize his production manager to buy machinery. The authorization process attempts to make sure that subordinates know the extent of their DELEGATED AUTHORITY.
Collins Dictionary of Business, 3rd ed. © 2002, 2005 C Pass, B Lowes, A Pendleton, L Chadwick, D O’Reilly and M Afferson
References in periodicals archive ?
In line with the ECHA provisions for authorisation, a group of 28 companies formed a consortium--Chromium VI Compounds for Surface Treatment REACH Authorization "CCST" to develop applications for authorisation of the most important Cr VI substances.
In the Transport Council in March, it was argued frequently that national authorities are best placed to assess the particularities of their sections and that any transfer of competences in terms of certification and authorisation should be approached with prudence.
Following review of the 1007 results by the EMA's Committee for Medicinal Products for Human Use (CHMP), the European Commission will consider converting the conditional marketing authorisation to a normal marketing authorization.
The second phase concerns medicines subjected to national authorisation procedures.
- the scope of authorisation: ministers emphasised the importance of applying scientific and technical criteria when taking into account dangerous substances to be included in the authorisation regime;
Under the terms of EU law (Regulation 1768/92), products already on the market when the legislation entered into force - as is the case with Losec - are only eligible for additional protection if the initial marketing authorisation was granted within certain deadlines.
Following a first appeal by Germany in 1995, the Commission called on the Member States in a Decision of December 9, 1996 to modify the clinical information accompanying authorisations for the medicinal products in question.